FGF2 and plasma cell myeloma: The neoangiogenesis evident in the bone marrow of subjects with myeloma is mediated by increased levels of basic fibroblast growth factor, vascular endothelial growth factor (VEGF), interleukin (IL)-lβ and tumour necrosis factor (TNF)-α.